Patent · US Active

Recurrent gene fusions in prostate cancer

US9957569B2 · kind B2 · utility

2Cited by

54References

23Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Arul M. Chinnaiyan · Plymouth, US
Bo Han · Los Angeles, US
Chandan Kumar · Bengaluru, IN

Key dates

Filing date	Nov 18, 2008
Grant date	May 1, 2018
Priority date	—
Expiry date	Nov 18, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Recurrent gene fusions in prostate cancer of androgen regulated genes or housekeeping genes and ETS family member genes are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.